IBDEI31L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,51004,1,3,0)
 ;;=3^Long term (current) use of systmc steroids
 ;;^UTILITY(U,$J,358.3,51004,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,51004,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,51005,0)
 ;;=Z79.1^^222^2466^187
 ;;^UTILITY(U,$J,358.3,51005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51005,1,3,0)
 ;;=3^Long term (current) use of NSAIDs
 ;;^UTILITY(U,$J,358.3,51005,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,51005,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,51006,0)
 ;;=M30.1^^222^2466^201
 ;;^UTILITY(U,$J,358.3,51006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51006,1,3,0)
 ;;=3^Polyarteritis w/ lung invlmnt [Churg-Strauss]
 ;;^UTILITY(U,$J,358.3,51006,1,4,0)
 ;;=4^M30.1
 ;;^UTILITY(U,$J,358.3,51006,2)
 ;;=^5011739
 ;;^UTILITY(U,$J,358.3,51007,0)
 ;;=M34.1^^222^2466^89
 ;;^UTILITY(U,$J,358.3,51007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51007,1,3,0)
 ;;=3^CR(E)ST syndrome
 ;;^UTILITY(U,$J,358.3,51007,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,51007,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,51008,0)
 ;;=D89.1^^222^2466^100
 ;;^UTILITY(U,$J,358.3,51008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51008,1,3,0)
 ;;=3^Cryoglobulinemia
 ;;^UTILITY(U,$J,358.3,51008,1,4,0)
 ;;=4^D89.1
 ;;^UTILITY(U,$J,358.3,51008,2)
 ;;=^29577
 ;;^UTILITY(U,$J,358.3,51009,0)
 ;;=M33.90^^222^2466^101
 ;;^UTILITY(U,$J,358.3,51009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51009,1,3,0)
 ;;=3^Dermatoplymyostis, unsp, organ invlvmnt, unspec
 ;;^UTILITY(U,$J,358.3,51009,1,4,0)
 ;;=4^M33.90
 ;;^UTILITY(U,$J,358.3,51009,2)
 ;;=^5011774
 ;;^UTILITY(U,$J,358.3,51010,0)
 ;;=L93.0^^222^2466^102
 ;;^UTILITY(U,$J,358.3,51010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51010,1,3,0)
 ;;=3^Discoid lupus erythematosus
 ;;^UTILITY(U,$J,358.3,51010,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,51010,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,51011,0)
 ;;=M1A.20X1^^222^2466^152
 ;;^UTILITY(U,$J,358.3,51011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51011,1,3,0)
 ;;=3^Gout, chron, drug-inducd, unsp site, w/tophus (tophi)
 ;;^UTILITY(U,$J,358.3,51011,1,4,0)
 ;;=4^M1A.20X1
 ;;^UTILITY(U,$J,358.3,51011,2)
 ;;=^5010926
 ;;^UTILITY(U,$J,358.3,51012,0)
 ;;=M10.9^^222^2466^157
 ;;^UTILITY(U,$J,358.3,51012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51012,1,3,0)
 ;;=3^Gout, unspecified
 ;;^UTILITY(U,$J,358.3,51012,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,51012,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,51013,0)
 ;;=M1A.00X1^^222^2466^153
 ;;^UTILITY(U,$J,358.3,51013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51013,1,3,0)
 ;;=3^Gout, chron, idiopath, unspec site, w/ tophus (tophi)
 ;;^UTILITY(U,$J,358.3,51013,1,4,0)
 ;;=4^M1A.00X1
 ;;^UTILITY(U,$J,358.3,51013,2)
 ;;=^5010858
 ;;^UTILITY(U,$J,358.3,51014,0)
 ;;=M10.00^^222^2466^156
 ;;^UTILITY(U,$J,358.3,51014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51014,1,3,0)
 ;;=3^Gout, idiopath, unspec site
 ;;^UTILITY(U,$J,358.3,51014,1,4,0)
 ;;=4^M10.00
 ;;^UTILITY(U,$J,358.3,51014,2)
 ;;=^5010284
 ;;^UTILITY(U,$J,358.3,51015,0)
 ;;=Z00.6^^222^2466^1
 ;;^UTILITY(U,$J,358.3,51015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51015,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,51015,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,51015,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,51016,0)
 ;;=Z00.6^^222^2466^134
 ;;^UTILITY(U,$J,358.3,51016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51016,1,3,0)
 ;;=3^Encntr for exam for nrml cmprsn & ctrl in clin rsrch prog
 ;;^UTILITY(U,$J,358.3,51016,1,4,0)
 ;;=4^Z00.6
 ;;^UTILITY(U,$J,358.3,51016,2)
 ;;=^5062608
 ;;^UTILITY(U,$J,358.3,51017,0)
 ;;=M79.7^^222^2466^135
 ;;^UTILITY(U,$J,358.3,51017,1,0)
 ;;=^358.31IA^4^2
